Gorman-Rupp (NYSE:GRC) reported quarterly earnings of $0.27 per share. This is a 15.62 percent decrease over earnings of $0.32 per share from the same period last year. The company reported quarterly sales of $119.10 million which beat the analyst consensus estimate of $98.60 million by 20.79 percent. This is a 28.04 percent increase over sales of $93.02 million the same period last year.
Axonics Expands Sacral Neuromodulation Intellectual Property Portfolio
Axonics, Inc. (NASDAQ:AXNX), a global medical technology company that is developing and commercializing novel products for the treatment of bladder and bowel dysfunction, today announced that in the last twelve months,
